Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer-oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical knowhow of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.
(i) Details of familiarization programmes imparted to Independent Directors including the following details:
(i) Number of programmes attended by independent directors (during the year and cumulative basis till date)
(ii) Number of hours spent by independent directors in such programs (during the year and cumulative basis till date)
(iii) Other relevant details
(l) Financial Information including:
(i) Notice of meeting of the board of directors where financial results shall be discussed
(ii) Financial results, on conclusion of the meeting of the board of directors where the financial results were approved
(iii) Complete copy of the annual report including balance sheet, profit and loss account, directors report, corporate governance report etc.
(n) Details of agreements entered into with the media companies and/or their associates, etc.
Not Applicable
(o) Schedule of analysts or institutional investors meet and presentations made by the listed entity to analysts or institutional investors
Explanation: For the purpose of this clause "meet" shall mean group meeting or group conference calls conducted physically or through digital means
(oa) Audio or video recordings and transcripts of post earnings/quarterly calls, by whatever name called, conducted physically or through digital means, simultaneously with submission to the recognized stock exchange(s), in the following manner:
(i) The presentation and the audio/video recordings shall be promptly made available on the website and in any case, before the next trading day or within twenty-four hours from the conclusion of such calls, whichever is earlier
(ii) The transcripts of such calls shall be made available on the website within five working days of the conclusion of such calls
(p) New name and the old name of the listed entity for a continuous period of one year, from the date of the last name change
Not Applicable
(q) Items published in the news paper
(a) Finanical results, as specified in regulation 33, along with the modified option(s) or reservation(s), if any, expressed by the auditor
(b) Notices given to shareholders by Advertisement
(r) All credit ratings obtained by the entity for all its outstanding instruments, updated immediately as and when there is any revision in any of the ratings
(s) Separate audited financial statements of each subsidiary of the listed entity in respect of a relevant financial year, uploaded at least 21 days prior to the date of the annual general meeting which has been called to inter alia consider accounts of that financial year
(v) Disclosure of contact details of key managerial personnel who are authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange(s)
